Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1994 2
1995 1
1996 3
1997 1
1998 4
1999 1
2000 1
2002 1
2005 1
2006 2
2007 2
2011 3
2012 5
2013 4
2014 5
2015 5
2016 2
2017 2
2018 1
2019 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis.
Xu J, Li SY, Almeida DV, Tasneen R, Barnes-Boyle K, Converse PJ, Upton AM, Mdluli K, Fotouhi N, Nuermberger EL. Xu J, et al. Among authors: mdluli k. Antimicrob Agents Chemother. 2019 Apr 25;63(5):e00021-19. doi: 10.1128/AAC.00021-19. Print 2019 May. Antimicrob Agents Chemother. 2019. PMID: 30833432 Free PMC article.
Advancing the Therapeutic Potential of Indoleamides for Tuberculosis.
Lun S, Tasneen R, Chaira T, Stec J, Onajole OK, Yang TJ, Cooper CB, Mdluli K, Converse PJ, Nuermberger EL, Raj VS, Kozikowski A, Bishai WR. Lun S, et al. Among authors: mdluli k. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00343-19. doi: 10.1128/AAC.00343-19. Print 2019 Jul. Antimicrob Agents Chemother. 2019. PMID: 31010860 Free PMC article.
Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.
R MM, Shandil R, Panda M, Sadler C, Ambady A, Panduga V, Kumar N, Mahadevaswamy J, Sreenivasaiah M, Narayan A, Guptha S, Sharma S, Sambandamurthy VK, Ramachandran V, Mallya M, Cooper C, Mdluli K, Butler S, Tommasi R, Iyer PS, Narayanan S, Chatterji M, Shirude PS. R MM, et al. Among authors: mdluli k. ACS Med Chem Lett. 2019 Sep 23;10(10):1480-1485. doi: 10.1021/acsmedchemlett.9b00343. eCollection 2019 Oct 10. ACS Med Chem Lett. 2019. PMID: 31620237 Free PMC article.
Tuberculosis drug discovery and emerging targets.
Mdluli K, Kaneko T, Upton A. Mdluli K, et al. Ann N Y Acad Sci. 2014 Sep;1323:56-75. doi: 10.1111/nyas.12459. Epub 2014 Jun 11. Ann N Y Acad Sci. 2014. PMID: 24920100 Review.
Novel targets for tuberculosis drug discovery.
Mdluli K, Spigelman M. Mdluli K, et al. Curr Opin Pharmacol. 2006 Oct;6(5):459-67. doi: 10.1016/j.coph.2006.06.004. Epub 2006 Aug 9. Curr Opin Pharmacol. 2006. PMID: 16904376 Review.
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action.
Wells WA, Boehme CC, Cobelens FG, Daniels C, Dowdy D, Gardiner E, Gheuens J, Kim P, Kimerling ME, Kreiswirth B, Lienhardt C, Mdluli K, Pai M, Perkins MD, Peter T, Zignol M, Zumla A, Schito M. Wells WA, et al. Among authors: mdluli k. Lancet Infect Dis. 2013 May;13(5):449-58. doi: 10.1016/S1473-3099(13)70025-2. Epub 2013 Mar 24. Lancet Infect Dis. 2013. PMID: 23531393 Free PMC article. Review.
A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.
Leung-Theung-Long S, Coupet CA, Gouanvic M, Schmitt D, Ray A, Hoffmann C, Schultz H, Tyagi S, Soni H, Converse PJ, Arias L, Kleinpeter P, Sansas B, Mdluli K, Vilaplana C, Cardona PJ, Nuermberger E, Marchand JB, Silvestre N, InchauspƩ G. Leung-Theung-Long S, et al. Among authors: mdluli k. PLoS One. 2018 May 2;13(5):e0196815. doi: 10.1371/journal.pone.0196815. eCollection 2018. PLoS One. 2018. PMID: 29718990 Free PMC article.
50 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page